Business Context and Reporting Period
This Form 8-K was filed by Senseonics Holdings, Inc. on December 9, 2021, reporting events occurring on December 8, 2021. The filing addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and compensation arrangements rather than financial performance.
Material Changes
The primary material change reported is the appointment of Sharon Larkin to the Board of Directors, effective immediately on December 8, 2021. She was designated as a Class I director with a term expiring at the 2023 annual meeting of stockholders. Additionally, she was appointed as a member of the Compensation Committee.
Guidance, Outlook, and Compensation
There is no guidance, outlook, or management commentary regarding future financial performance in this filing. The document details the following compensatory arrangements for Ms. Larkin:
- Equity Grant: 72,115 restricted stock units (RSUs) of common stock, vesting in three equal annual installments contingent on continuous service.
- Annual Retainer: $40,000 for service as a director.
- Committee Fee: $6,500 for service as a member of the Compensation Committee.
- Indemnification: Ms. Larkin is expected to enter into the Company's standard form of indemnification agreement.
No risks, contingencies, or unusual items were disclosed in this specific report.
Investor Verification Checklist
- Verify the vesting schedule and performance conditions for the 72,115 RSUs granted to Sharon Larkin.
- Confirm the total annual cash compensation ($46,500) against the company's existing non-employee director compensation policy.
- Review Ms. Larkin's background in medical device human resources (Abbott, Assertio Therapeutics) for potential strategic alignment with Senseonics' operations.
- Check for any subsequent filings regarding the execution of the standard indemnification agreement.